Skip to main navigation Skip to search Skip to main content

ABBOTT: A 10-Year, Post-marketing, Observational, Registry to Assess Long Term Safety of HUMIRA (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis

Project: Research

Project Details

StatusFinished
Effective start/end date08/17/12 → 04/5/14

Funding

  • United BioSource Corporation: $4,375.00